Huons Global Co., Ltd. (084110.KQ)
KRW 46750.0
(-0.53%)
KRW 46750.0
(-0.53%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3133.85 KRW | 163.92% |
| 2022 | -4902.93 KRW | -1625.44% |
| 2021 | 321.41 KRW | -91.01% |
| 2020 | 3573.50 KRW | 60.45% |
| 2019 | 2227.21 KRW | -8.57% |
| 2018 | 2435.94 KRW | 18.8% |
| 2017 | 2050.37 KRW | 5.4% |
| 2016 | 1945.28 KRW | -57.15% |
| 2015 | 4539.96 KRW | 54.03% |
| 2014 | 2947.38 KRW | 16.92% |
| 2013 | 2520.87 KRW | 134.32% |
| 2012 | 1075.82 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 832.00 KRW | -6.88% |
| 2024 Q1 | 893.49 KRW | -14.13% |
| 2023 FY | - KRW | 163.92% |
| 2023 Q1 | 547.51 KRW | 109.03% |
| 2023 Q4 | 1040.48 KRW | 15.19% |
| 2023 Q2 | 642.61 KRW | 17.37% |
| 2023 Q3 | 903.25 KRW | 40.56% |
| 2022 Q4 | -6063.51 KRW | -1345.38% |
| 2022 Q1 | 450.21 KRW | 137.2% |
| 2022 FY | - KRW | -1625.44% |
| 2022 Q2 | 200.88 KRW | -55.38% |
| 2022 Q3 | 486.88 KRW | 142.37% |
| 2021 Q1 | 587.95 KRW | -60.6% |
| 2021 Q2 | 527.63 KRW | -10.26% |
| 2021 Q3 | 358.16 KRW | -32.12% |
| 2021 Q4 | -1210.13 KRW | -437.87% |
| 2021 FY | - KRW | -91.01% |
| 2020 Q2 | 756.55 KRW | 36.85% |
| 2020 Q3 | 887.63 KRW | 17.33% |
| 2020 Q4 | 1492.42 KRW | 68.14% |
| 2020 Q1 | 552.82 KRW | -11.39% |
| 2020 FY | - KRW | 60.45% |
| 2019 Q4 | 623.90 KRW | 7.46% |
| 2019 Q3 | 580.57 KRW | 19.24% |
| 2019 Q2 | 486.88 KRW | -11.16% |
| 2019 Q1 | 548.04 KRW | 150.68% |
| 2019 FY | - KRW | -8.57% |
| 2018 FY | - KRW | 18.8% |
| 2018 Q4 | 218.62 KRW | -74.43% |
| 2018 Q3 | 854.86 KRW | 25.49% |
| 2018 Q2 | 681.23 KRW | 15.91% |
| 2018 Q1 | 587.74 KRW | -20.34% |
| 2017 Q4 | 737.82 KRW | 29.41% |
| 2017 Q1 | 357.81 KRW | 51.27% |
| 2017 Q2 | 502.52 KRW | 40.44% |
| 2017 Q3 | 570.13 KRW | 13.45% |
| 2017 FY | - KRW | 5.4% |
| 2016 Q2 | 179.36 KRW | 126.69% |
| 2016 Q4 | 236.54 KRW | -18.19% |
| 2016 Q3 | 289.12 KRW | 61.2% |
| 2016 Q1 | 79.12 KRW | 242.17% |
| 2016 FY | - KRW | -57.15% |
| 2015 Q2 | 27.29 KRW | 12.82% |
| 2015 Q4 | -55.65 KRW | -160.5% |
| 2015 Q3 | 91.99 KRW | 237.08% |
| 2015 FY | - KRW | 54.03% |
| 2015 Q1 | 24.19 KRW | -96.6% |
| 2014 Q3 | 821.19 KRW | 11.07% |
| 2014 Q1 | 674.49 KRW | 84.21% |
| 2014 Q2 | 739.34 KRW | 9.61% |
| 2014 Q4 | 711.66 KRW | -13.34% |
| 2014 FY | - KRW | 16.92% |
| 2013 Q2 | 660.45 KRW | 15.63% |
| 2013 FY | - KRW | 134.32% |
| 2013 Q1 | 571.19 KRW | 130.88% |
| 2013 Q3 | 926.23 KRW | 40.24% |
| 2013 Q4 | 366.15 KRW | -60.47% |
| 2012 FY | - KRW | 0.0% |
| 2012 Q4 | 247.40 KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | -666.05 KRW | 570.513% |
| CMG Pharmaceutical Co., Ltd. | 46.00 KRW | -6712.717% |
| Celltrion Pharm, Inc. | 539.00 KRW | -481.419% |
| DongKook Pharmaceutical Co., Ltd. | 1073.13 KRW | -192.029% |
| Enzychem Lifesciences Corporation | -109.81 KRW | 2953.884% |
| Humedix Co., Ltd. | 2512.11 KRW | -24.75% |
| Boditech Med Inc. | 1181.00 KRW | -165.356% |
| EuBiologics Co., Ltd. | -381.00 KRW | 922.533% |
| FutureChem Co.,Ltd | -303.61 KRW | 1132.196% |
| Huons Co., Ltd. | 4261.00 KRW | 26.453% |
| BNC Korea Co., Ltd. | 388.00 KRW | -707.693% |
| AptaBio Therapeutics Inc. | -540.91 KRW | 679.366% |